These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2783485)

  • 1. Identification of murine complement receptor type 2.
    Fingeroth JD; Benedict MA; Levy DN; Strominger JL
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):242-6. PubMed ID: 2783485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
    Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative structure and evolution of murine CR2. The homolog of the human C3d/EBV receptor (CD21).
    Fingeroth JD
    J Immunol; 1990 May; 144(9):3458-67. PubMed ID: 2139457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ; Tedder TF; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes.
    Moore MD; Cooper NR; Tack BF; Nemerow GR
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9194-8. PubMed ID: 2827171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.
    Molina H; Brenner C; Jacobi S; Gorka J; Carel JC; Kinoshita T; Holers VM
    J Biol Chem; 1991 Jul; 266(19):12173-9. PubMed ID: 1712014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor.
    Ahearn JM; Hayward SD; Hickey JC; Fearon DT
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9307-11. PubMed ID: 2848261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
    Delcayre AX; Salas F; Mathur S; Kovats K; Lotz M; Lernhardt W
    EMBO J; 1991 Apr; 10(4):919-26. PubMed ID: 1849076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins.
    Weis JJ; Toothaker LE; Smith JA; Weis JH; Fearon DT
    J Exp Med; 1988 Mar; 167(3):1047-66. PubMed ID: 2832506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry.
    Kurtz CB; Paul MS; Aegerter M; Weis JJ; Weis JH
    J Immunol; 1989 Sep; 143(6):2058-67. PubMed ID: 2528587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2.
    Hedrick JA; Watry D; Speiser C; O'Donnell P; Lambris JD; Tsoukas CD
    Eur J Immunol; 1992 May; 22(5):1123-31. PubMed ID: 1315687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
    Carel JC; Frazier B; Ley TJ; Holers VM
    J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.
    Lambris JD; Dobson NJ; Ross GD
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1828-32. PubMed ID: 6101236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.
    Fingeroth JD; Weis JJ; Tedder TF; Strominger JL; Biro PA; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4510-4. PubMed ID: 6087328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).
    Nemerow GR; Wolfert R; McNaughton ME; Cooper NR
    J Virol; 1985 Aug; 55(2):347-51. PubMed ID: 2410629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor.
    Fujisaku A; Harley JB; Frank MB; Gruner BA; Frazier B; Holers VM
    J Biol Chem; 1989 Feb; 264(4):2118-25. PubMed ID: 2563370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor.
    Kinoshita T; Thyphronitis G; Tsokos GC; Finkelman FD; Hong K; Sakai H; Inoue K
    Int Immunol; 1990; 2(7):651-9. PubMed ID: 1703784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site.
    Myones BL; Ross GD
    Complement; 1987; 4(2):87-98. PubMed ID: 3497773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.
    Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD
    J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.